Bullous pemphigoid during the treatment of psoriasis vulgaris with risankizumab

J Dermatol. 2023 Feb;50(2):e72-e73. doi: 10.1111/1346-8138.16534. Epub 2022 Jul 29.

Authors

Norihito Fukada¹, Tomohiro Suzuki¹, Kazuhiro Aoyama¹, Akihiko Kinjo¹, Kazuto Yamazaki², Tomotaka Sato¹

Affiliations

¹ Department of Dermatology, Teikyo University Chiba Medical Center, Chiba, Japan.
² Department of Pathology, Teikyo University Chiba Medical Center, Chiba, Japan.

PMID: 35904019
DOI: 10.1111/1346-8138.16534

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal
Humans
Pemphigoid, Bullous* / chemically induced
Pemphigoid, Bullous* / diagnosis
Pemphigoid, Bullous* / drug therapy
Psoriasis* / diagnosis
Psoriasis* / drug therapy

Substances

risankizumab
Antibodies, Monoclonal